What plan sponsors should know ahead of rollout of new obesity drugs in Canada
A new generation of glucagon-like peptide-1 drugs approved for the treatment of obesity will soon be available in Canada, presenting an opportunity for plan sponsors…
- By: Sadie Janes
- April 1, 2024 March 28, 2024
- 09:00